About Viyash Life Sciences Private Limited
Data last updated:
Viyash Life Sciences Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 21 February 2019.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2019PTC130774. Its GSTIN is 36AAGCV8177Q1Z9 (Telangana). The company held 4 GST registrations, of which 3 are active.
The company had an authorised share capital of ₹801.45 Cr and a paid-up capital of ₹343.48 Cr. It was led by directors including Kalidindi Srihari Raju (Whole-Time Director) and Hari Babu Bodepudi (Whole-Time Director).
Its last annual general meeting (AGM) was held on 18 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office was at Plot No.290 Srivalli'S Corporate Road No.6 Kakatiya Hills Madhapur, Hyderabad, Telangana, India – 500081.
As per the financials filed for FY 2025, the company reported a revenue of ₹228.27 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net loss of ₹16.46 Cr (net margin -7.2%) and EBITDA of ₹166.78 Cr (EBITDA margin 73.1%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years.
Its group structure included 4 subsidiaries.
The company was associated with 1 brand: Viyash. As per MCA filings, the company had open charges of ₹43.74 Cr on record. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 1 case is pending. The company has 9 deals on record (5 funding rounds, 3 rights issues, 1 secondary share transfer), with disclosed funding of ₹1,923.2 Cr; the latest was in July 2024. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Dishman Pharmaceuticals and Chemicals Limited with revenue of ₹1,622.59 Cr.
The last known website on record is viyash.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No.290 Srivalli'S Corporate Road No.6 Kakatiya Hills Madhapur, Hyderabad, Telangana, India – 500081
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands
Viyash Life Sciences operates one associated brand: Viyash. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| APIs and intermediates are manufactured by Viyash as a CDMO. | viyash.com |
Business Activity
The main business activities of Viyash Life Sciences are manufacturing, professional, scientific and technical and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, scientific research and development and retail trading. 3 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Viyash Life Sciences Private Limited
FY 2025 filings availableViyash Life Sciences Private Limited reported revenue of ₹228.27 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 17% over three years, including 9% growth in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | ₹228.27 Cr | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹166.78 Cr | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | -₹16.46 Cr | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 73.1% | |
| Net Profit Margin | -7.2% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2020-21 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Viyash Life Sciences are in the company report.
: available in the company report
Board of Directors of Viyash Life Sciences Private Limited
Viyash Life Sciences has 8 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Kaul | Nominee Director | 04 Jan 2023 | 3 Years 9 Months | As last reported |
| Pradip Manilal Kanakia Also directs: Healthcare Global Enterprises Limited, Britannia Industries Ltd, Sona BLW Precision Forgings Limited and 5 more | Director | 20 Dec 2021 | 4 Years 10 Months | As last reported |
| Kalidindi Srihari Raju Also directs: Pokepola Enterprises LLP | Whole-Time Director | 07 Aug 2019 | 7 Years 2 Months | As last reported |
| Kamal Kishore Sharma Also directs: Templecraft Realty LLP, Templeriviere Property LLP, Temple Wellness Ventures LLP and 5 more | Director | 01 Dec 2022 | 3 Years 10 Months | As last reported |
| Gurveen Singh Also directs: VLCC Limited, Eureka Forbes Limited | Director | 24 Mar 2022 | 4 Years 6 Months | As last reported |
| Anuj Vishnukumar Poddar | Director | 13 Nov 2024 | 1 Years 11 Months | As last reported |
Peer Comparison
Viyash Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dishman Pharmaceuticals and Chemicals Limited | ₹1,622.59 Cr (FY 2016) | •••• | •••• | -3.0% | •••• | Ahmedabad, Gujarat, India |
| Viyash Scientific Limited Listed | ₹1,566.06 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Hyderabad, Telangana, India |
| Virchow Petrochemical Private Limited | ₹1,499.36 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Patancheru, Telangana, India |
| Neuland Laboratories Ltd. Listed | ₹1,497.35 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Hyderabad, Telangana, India |
| Virchow Laboratories Limited | ₹1,479.64 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Telangana, India |
| Teva Api India Private Limited | ₹1,456.07 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Mumbai, Maharashtra, India |
| Dhanuka Laboratories Limited | ₹1,424.06 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Chennai, Tamil Nadu, India |
| Harman Finochem Limited | ₹1,376.43 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Mumbai, Maharashtra, India |
| Viyash Life Sciences Private Limited this company | ₹228.27 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Hyderabad, Telangana, India |
Peers are the companies nearest to Viyash Life Sciences by revenue, above and below it, in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details
Viyash Life Sciences Private Limited is audited by Deloitte Haskins & Sells for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Deloitte Haskins & Sells | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Oct 2025 | Hdfc Bank Limited | ₹38.92 Lakh | Open |
| 25 Sep 2025 | Hdfc Bank Limited | ₹17.54 Lakh | Open |
| 05 Mar 2025 | Hdfc Bank Limited | ₹24.64 Lakh | Open |
| 28 Jan 2025 | Hdfc Bank Limited | ₹7.49 Cr | Open |
| 18 Oct 2022 | Hdfc Bank Limited | ₹2 Cr | Open |
Total charge records: 8 View all charges
Deals & Funding
Viyash Life Sciences Private Limited has 9 deals on record (5 funding rounds, 3 rights issues, 1 secondary share transfer), with disclosed funding of ₹1,923.2 Cr; the latest was in July 2024.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2024 | Rights issue | ₹312.6 Cr | Investors: The Carlyle Group, Rajkamal Family Trust, 2 individuals |
| Jan 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Nov 2021 | Funding round | ₹91.66 Cr | Investors: 2 individuals |
| Apr 2020 | Rights issue | ₹9.55 Cr | Investors: 4 individuals |
| Nov 2019 | Funding round | ₹14.65 Cr | Investors: Pharminn Enterprises LLP , 3 individuals |
: available in the company report
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases
Viyash Life Sciences Private Limited has 4 court cases on record: 3 filed by Viyash Life Sciences, 1 filed against it. 1 case is pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 1 | 1 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd., and 1 other | Disposed |
| High Court, TELANGANA | Criminal complaint | Filed by the company against an individual | Pending |
| High Court, TELANGANA | Court case (COMCA) | Filed against the company by an individual | Disposed |
| Supreme Court | Court case (1100-Arbitration Matters : SLPs challenging Arbitration Matters) | Filed by the company against individuals | Disposed |
: available in the company report
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Viyash Life Sciences.
: available in the company report
Group Structure
Viyash Life Sciences has 4 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Symed Labs Limited | U24231TG1998PLC029961 | Locked |
| Appcure Labs Private Limited | U24232TG2012PTC084625 | Locked |
| Vandana Life Sciences Private Limited | U24239TG2002PTC040132 | Locked |
| Vindhya Pharma (India) Private Limited | U24296TG2006PTC050700 | Locked |
Showing major subsidiaries. Total: 4.
Recent Activity
Viyash Life Sciences Private Limited has 14 board changes on record since 2019: 8 appointments and 6 cessations. The latest: Anuj Vishnukumar Poddar was appointed as Director on 13 Nov 2024.
14 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Viyash Life Sciences has 4 GST registrations: 3 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCV8177Q1Z9 | Telangana | Active | 13 Sep 2019 |
| 37AAGCV8177Q1Z7 | Andhra Pradesh | Active | 22 Jan 2021 |
| 27AAGCV8177Q1Z8 | Maharashtra | Active | 03 Feb 2021 |
: available in the company report
MCA Filings & Documents
: available in the company report
Related news
Frequently Asked Questions
Viyash Life Sciences has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Viyash Life Sciences was a private limited company based in Hyderabad, Telangana, India. The company worked in api manufacturers, within the pharma industry. It was incorporated on 21 February 2019 and is registered under CIN U24239TG2019PTC130774. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Viyash Life Sciences was incorporated on 21 February 2019. It is registered with the Registrar of Companies, Hyderabad.
Viyash Life Sciences had 8 directors:
- Kalidindi Srihari Raju - Whole-Time Director
- Hari Babu Bodepudi - Whole-Time Director
- Sunil Kaul - Nominee Director
- Pradip Manilal Kanakia - Director
- Kamal Kishore Sharma - Director
- Gurveen Singh - Director
- Anuj Vishnukumar Poddar - Director
- Amit Jain - Nominee Director
The CIN (Corporate Identification Number) of Viyash Life Sciences is U24239TG2019PTC130774. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Viyash Life Sciences is at Plot No.290 SrivalliS Corporate Road No.6 Kakatiya Hills Madhapur, Hyderabad, Telangana, India – 500081.
Viyash Life Sciences can be reached through the website viyash.com. Its registered office is in Hyderabad, Telangana, India.
The latest financial statements of Viyash Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 18 July 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Viyash Life Sciences is 36AAGCV8177Q1Z9, registered in Telangana. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 37AAGCV8177Q1Z7 (Andhra Pradesh), 27AAGCV8177Q1Z8 (Maharashtra).
Viyash Life Sciences operated in the pharma industry, in the api manufacturers segment.
Viyash Life Sciences has 9 deals on record (5 funding rounds, 3 rights issues, 1 secondary share transfer), with disclosed funding of ₹1,923.2 Cr; the latest was in July 2024.